Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
Dutch Colorectal Cancer Group
National Cancer Institute (NCI)
National University Hospital, Singapore
Soroka University Medical Center